disclosure document released, page-4

Much of interest in there SSV. A couple of things that jump out:

1. China of course - detection study has already been submitted to MPS

2. Probeline (testing residues in the home) - likes like a very solid prospect

3. Mexico still in the mix

4. Russia approvals tracking ahead of schedule

5. Manufacture of Visualine in Mexico - lower cost allows addition of 2 more drugs (up to 12)

6. Continuing expansion of distributors and TPA in US

7. Marketing to distributors in UK in conjunction with launch of Oraline 8

Only slight disappointment was delay in launch of Oraline 8 to Oct

Looking very good indeed!!!